Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

NCT00393211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Low Back Pain

Interventions

DRUG: MK0663, Etoricoxib / Duration of Treatment : 12 Weeks
DRUG: Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks

Sponsor

Organon and Co